# Tolerance of Intra-articular Injection Autologous Stromal Vascular Fraction for the Treatment of Rhizarthrosis

> **NCT05708430** · PHASE2 · RECRUITING · sponsor: **University Hospital, Rouen** · enrollment: 12 (estimated)

## Conditions studied

- Rhizarthrosis

## Interventions

- **DRUG:** SVF injection into wrist

## Key facts

- **NCT ID:** NCT05708430
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-15
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05708430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05708430, "Tolerance of Intra-articular Injection Autologous Stromal Vascular Fraction for the Treatment of Rhizarthrosis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05708430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*